Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma. [electronic resource]
Producer: 20060228Description: 748-54 p. digitalISSN:- 1527-7755
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Camptothecin -- administration & dosage
- Carcinoma -- drug therapy
- Combined Modality Therapy
- Disease-Free Survival
- Docetaxel
- Esophageal Neoplasms -- drug therapy
- Female
- Fluorouracil -- administration & dosage
- Gene Expression Profiling
- Humans
- Immunohistochemistry
- Infusions, Intravenous
- Injections, Intravenous
- Irinotecan
- Male
- Middle Aged
- NF-kappa B -- analysis
- Neoplasm Invasiveness
- Neoplasm Staging -- methods
- Prognosis
- Taxoids -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.